98 related articles for article (PubMed ID: 17276401)
1. The death domain of IRAK-1: an oligomerization domain mediating interactions with MyD88, Tollip, IRAK-1, and IRAK-4.
Neumann D; Kollewe C; Resch K; Martin MU
Biochem Biophys Res Commun; 2007 Mar; 354(4):1089-94. PubMed ID: 17276401
[TBL] [Abstract][Full Text] [Related]
2. Threonine 66 in the death domain of IRAK-1 is critical for interaction with signaling molecules but is not a target site for autophosphorylation.
Neumann D; Kollewe C; Pich A; Cao P; Resch K; Martin MU
J Leukoc Biol; 2008 Sep; 84(3):807-13. PubMed ID: 18524972
[TBL] [Abstract][Full Text] [Related]
3. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor.
Burns K; Clatworthy J; Martin L; Martinon F; Plumpton C; Maschera B; Lewis A; Ray K; Tschopp J; Volpe F
Nat Cell Biol; 2000 Jun; 2(6):346-51. PubMed ID: 10854325
[TBL] [Abstract][Full Text] [Related]
4. Identification, characterization and the interaction of Tollip and IRAK-1 in grass carp (Ctenopharyngodon idellus).
Huang R; Lv J; Luo D; Liao L; Zhu Z; Wang Y
Fish Shellfish Immunol; 2012 Sep; 33(3):459-67. PubMed ID: 22659441
[TBL] [Abstract][Full Text] [Related]
5. MyD88-induced downregulation of IRAK-4 and its structural requirements.
Hatao F; Yamamoto M; Muroi M; Kaminishi M; Tanamoto K
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):260-4. PubMed ID: 18503546
[TBL] [Abstract][Full Text] [Related]
6. Contribution of globular death domains and unstructured linkers to MyD88.IRAK-4 heterodimer formation: an explanation for the antagonistic activity of MyD88s.
Mendoza-Barberá E; Corral-Rodríguez MA; Soares-Schanoski A; Velarde M; Macieira S; Messerschmidt A; López-Collazo E; Fuentes-Prior P
Biochem Biophys Res Commun; 2009 Feb; 380(1):183-7. PubMed ID: 19167362
[TBL] [Abstract][Full Text] [Related]
7. Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through induction of Tollip and negative regulation of IRAK-1.
Watts BA; Tamayo E; Sherwood ER; Good DW
Am J Physiol Renal Physiol; 2019 Sep; 317(3):F705-F719. PubMed ID: 31241993
[TBL] [Abstract][Full Text] [Related]
8. Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling.
Kollewe C; Mackensen AC; Neumann D; Knop J; Cao P; Li S; Wesche H; Martin MU
J Biol Chem; 2004 Feb; 279(7):5227-36. PubMed ID: 14625308
[TBL] [Abstract][Full Text] [Related]
9. Bacterial lipoprotein-induced self-tolerance and cross-tolerance to LPS are associated with reduced IRAK-1 expression and MyD88-IRAK complex formation.
Li CH; Wang JH; Redmond HP
J Leukoc Biol; 2006 Apr; 79(4):867-75. PubMed ID: 16461741
[TBL] [Abstract][Full Text] [Related]
10. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
[TBL] [Abstract][Full Text] [Related]
11. TRAF6 distinctively mediates MyD88- and IRAK-1-induced activation of NF-kappaB.
Muroi M; Tanamoto K
J Leukoc Biol; 2008 Mar; 83(3):702-7. PubMed ID: 18070982
[TBL] [Abstract][Full Text] [Related]
12. Grouper (Epinephelus coioides) MyD88 and Tollip: intracellular localization and signal transduction function.
Li YW; Wang Z; Mo ZQ; Li X; Luo XC; Dan XM; Li AX
Fish Shellfish Immunol; 2015 Jan; 42(1):153-8. PubMed ID: 25449381
[TBL] [Abstract][Full Text] [Related]
13. Regulation of IRAK-1 activation by its C-terminal domain.
Nguyen T; De Nardo D; Masendycz P; Hamilton JA; Scholz GM
Cell Signal; 2009 May; 21(5):719-26. PubMed ID: 19166926
[TBL] [Abstract][Full Text] [Related]
14. Functional assessment of the mutational effects of human IRAK4 and MyD88 genes.
Yamamoto T; Tsutsumi N; Tochio H; Ohnishi H; Kubota K; Kato Z; Shirakawa M; Kondo N
Mol Immunol; 2014 Mar; 58(1):66-76. PubMed ID: 24316379
[TBL] [Abstract][Full Text] [Related]
15. The C2 domain of Tollip, a Toll-like receptor signalling regulator, exhibits broad preference for phosphoinositides.
Ankem G; Mitra S; Sun F; Moreno AC; Chutvirasakul B; Azurmendi HF; Li L; Capelluto DG
Biochem J; 2011 May; 435(3):597-608. PubMed ID: 21294713
[TBL] [Abstract][Full Text] [Related]
16. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.
Loiarro M; Capolunghi F; Fantò N; Gallo G; Campo S; Arseni B; Carsetti R; Carminati P; De Santis R; Ruggiero V; Sette C
J Leukoc Biol; 2007 Oct; 82(4):801-10. PubMed ID: 17548806
[TBL] [Abstract][Full Text] [Related]
17. Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors.
O'Neill LA; Dunne A; Edjeback M; Gray P; Jefferies C; Wietek C
J Endotoxin Res; 2003; 9(1):55-9. PubMed ID: 12691620
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
[TBL] [Abstract][Full Text] [Related]
19. The N-terminal loop of IRAK-4 death domain regulates ordered assembly of the Myddosome signalling scaffold.
Dossang AC; Motshwene PG; Yang Y; Symmons MF; Bryant CE; Borman S; George J; Weber AN; Gay NJ
Sci Rep; 2016 Nov; 6():37267. PubMed ID: 27876844
[TBL] [Abstract][Full Text] [Related]
20. Constitutive association of MyD88 to IRAK in HTLV-I-transformed T cells.
Mizobe T; Tsukada J; Higashi T; Mouri F; Matsuura A; Tanikawa R; Minami Y; Yoshida Y; Tanaka Y
Exp Hematol; 2007 Dec; 35(12):1812-22. PubMed ID: 17920759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
